Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Walgreens Pharmacy Sales Up 19% In December; End Of Rx Slowdown?

  • News

Executive Summary

Walgreens is reporting double-digit prescription volume increases heading into 2004

You may also be interested in...



Walgreens Rx Share Growth Outpaces Mail; Strong Pharmacy Sales Continue

Walgreens is gaining share in the U.S. prescription drug market at a faster pace than mail order or any other retail segment, the company declared in its fiscal second quarter earnings release March 22

Walgreens Rx Share Growth Outpaces Mail; Strong Pharmacy Sales Continue

Walgreens is gaining share in the U.S. prescription drug market at a faster pace than mail order or any other retail segment, the company declared in its fiscal second quarter earnings release March 22

Walgreens 90-Day Retail Rx Program Offers 17% Discount On Copay

Walgreens is offering 90-day retail prescriptions at a copay that is two-and-a-half times the copay of a 30-day prescription

Table

View full table

Tags:
Latest Headlines

Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings

China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’

Change Is Constant For Pneumococcal Vaccines: US CDC Prepares For Merck’s V116

Woodcock Takes On Rare Disease Challenges In Retirement, Keeps FDA, Industry At Arm’s Length

See All
UsernamePublicRestriction

Register

PS043149

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By